Skip to main content
SpringerLink
Log in

Successes and Limitations of Antiarrhythmic Drug Therapy

  • Chapter
Book cover Antiarrhythmic Drugs

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 89))

  • 178 Accesses

Abstract

This book testifies to the growing fund of knowledge, both at the basic scientific and at the clinical level, concerning the electrophysiological effects of antiarrhythmic drugs. A large number of antiarrhythmic agents are available for clinical use. All are of proven efficacy. Yet the question remains: is a particular agent going to benefit a particular patient?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bastian BC, McFarlane PW, McLauchlan JH, Ballantyne D, Clark R, Hillis WS, Rae AP, Hutton I (1980) A prospective randomised trial of tocainide in patients following myocardial infarction. Am Heart J 100: 1017–1022

    Article  PubMed  CAS  Google Scholar 

  • Beta-Blocker Heart Attack Trial Research Group (BHAT) (1982) A randomised trial of propranolol in patients with acute myocardial infarction. JAMA 247: 1707–1714

    Google Scholar 

  • Bjerregaard P (1983) Premature beats in healthy subjects 40-79 years of age. Eur Heart J 3: 493–503

    Google Scholar 

  • Bourke JP, Cowan JC, Tansuphaswadikul S, Campbell RWF (1987) Antiarrhythmic drug effects on left ventricular performance. Eur Heart J [Suppl A], 8: 105–111

    Google Scholar 

  • Chamberlain DA, Jewitt DE, Julian DG, Campbell RWF, Boyle DMcC, Shanks RG (1980) Oral mexiletine in high-risk patients after myocardial infarction. Lancet 2: 1324–1327

    Google Scholar 

  • Collaborative Group (1971) Phenytoin after recovery from myocardial infarction: controlled trial in 568 patients. Lancet 2: 1055–1057

    Google Scholar 

  • Cowan JC, Bourke J, Campbell RWF (1987) Arrhythmogenic effects of antiarrhythmic drugs. Eur Heart J [Suppl A], 8: 133–136

    Google Scholar 

  • Dewhurst NG, Hannan WJ, Muir AL (1984) Ventricular performance and prognosis after primary ventricular fibrillation complicating acute myocardial infarction. Eur Heart J 5: 275–281

    Google Scholar 

  • Dubois C, Smeets JP, Demoulin C, Foidart G, Henrard L, Tulippe C, Preston L, earlier J, Kulbertus HE (1986) Incidence, clinical significance and prognosis of ventricular fibrillation in the early phase of myocardial infarction. Eur Heart J 7: 945–951

    PubMed  CAS  Google Scholar 

  • Friedman L, Yusuf S (1986) Does therapy directed by programmed electrical stimulation provide a satisfactory clinical response? Circulation [Suppl 2] 73: 59–66

    Google Scholar 

  • Gallagher JJ, Sealy WC, Selle JG, Svenson RH, Zimmern SH (1986) Role of ablation techniques and surgery in the treatment of cardiac arrhythmias. In: Kulbertus HE (ed) Medical management of cardiac arrhythmias. Livingstone, Edinburgh, pp 253–283

    Google Scholar 

  • Hinkle LE, Carver ST, Stevens M (1969) The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged men. Am J Cardiol 24: 629–650

    Article  PubMed  Google Scholar 

  • Hugenholtz PG, Hagemeijer F, Lubsen J, Glaser B, van Durme JP, Bogaert MG (1978) One year follow-up in patients with persistent ventricular dysrhythmias after myo-cardial infarction treated with aprindine and placebo. In: Sandoe E, Julian DG, Bell J (eds) Management of ventricular tachycardia—role of mexiletine. Excerpta Medica, Amsterdam, pp 572–578

    Google Scholar 

  • IMPACT Research Group (1984) International mexiletine and placebo antiarrhythmic coronary trial. I. Report on arrhythmia and other findings. J Am Coll Cardiol 4: 1148–1163

    Google Scholar 

  • Kertes P, Hunt D (1984) Prophylaxis of primary ventricular fibrillation in acute myocardial infarction. The case against lignocaine. Br Heart J 52: 241–247

    Google Scholar 

  • Koster RW, Dunning AJ (1985) Intramuscular lidocaine for the prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction. N Engl J Med 313: 1105–1110

    Article  Google Scholar 

  • Lawrie DM, Higgins MR, Godman MJ, Oliver MF, Julian DG, Donald KW (1968) Ventricular fibrillation complicating acute myocardial infarction. Lancet 2: 523–528

    Article  PubMed  CAS  Google Scholar 

  • Leinbach RC, Chamberlain DA, Kastor JA, Harthrone JW, Sanders CA (1969) A com-parison of the haemodynamic effects of ventricular and sequential A-V pacing in patients with heart block. Am Heart J 78: 502–508

    Article  PubMed  CAS  Google Scholar 

  • May GS, Eberlein KA, Furberg CD, Passamani ER, DeMets DL (1982) Secondary prevention after myocardial infarction: a review of long-term trials. Prog. Cardiovasc Dis 24: 331–352

    Google Scholar 

  • Morganroth J, Horowitz LN (1984) Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram. Am J Cardiol 53: 89B–94B

    Article  PubMed  CAS  Google Scholar 

  • Moss AJ, Davis HT, DeCamilla J, Bawer LW (1979) Ventricular ectopic beats and their relation to sudden and non-sudden cardiac death after myocardial infarction. Circulation 60: 998–1003

    Google Scholar 

  • Nademanee K, Hendrickson J, Hannan R, Singh BN (1982) Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneous ventricular tachyarrhythmias vs inconsistent abolition of induced VT. Am Heart J 103: 950–959

    Article  Google Scholar 

  • Nakano J, McCloy RB (1970) Effects of atrial and ventricular tachycardia on systemic and coronary circulations, and myocardial oxygen consumption in control dogs and in dogs with adrenergic blockade. Cardiovasc Res 4: 180–187

    Article  Google Scholar 

  • Norwegian Multicentre Research Group (1981) Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304: 801–807

    Google Scholar 

  • Peter T, Ross D, Duffield A, Luxton M, Harper R, Hunt D, Sloman G (1978) Effect on survival after myocardial infarction of long-term treatment with phenytoin. Br Heart J 40: 1356–1360

    Article  PubMed  CAS  Google Scholar 

  • Rokseth R, Storstein O (1963) Quinidine therapy of chronic ventricular fibrillation. The occurrence and mechanisms of syncope. Arch Intern Med 111: 102–107

    Google Scholar 

  • Ruskin JN, McGovern B, Garan H, DiMarco JP, Kelly E (1983) Antiarrhythmic drugs: a possible cause of out-of-hospital cardiac arrest. N Engl J Med 309: 1302–1306

    Article  PubMed  CAS  Google Scholar 

  • Ryden L, Amman K, Conradson T-B, Hofvendsahl S, Mortensen O, Smedsard P (1980) Prophylaxis of ventricular tachyarrhythmias with intravenous and oral toc- ainide in patients with and recovering from acute myocardial infarction. Am Heart J 100: 1006–1012

    Article  Google Scholar 

  • Scheinman MM, Davis JC (1986) Catheter ablation for treatment of tachyarrhythmias: present role and potential promise. Circulation 73: 10–13

    Article  PubMed  CAS  Google Scholar 

  • Schwartz PJ, Zara A, Grazi S, Lombardo M, Lotto A, Sbressa C, Zappa P (1985) Effect of ventricular fibrillation complicating acute myocardial infarction on long-term prognosis: importance of the site of infarction. Am J Cardiol 56: 384–389

    Article  Google Scholar 

  • Sheu SS, Lederer WJ (1985) Lidocaine’s negative inotropic and antiarrhythmic actions. Circ Res 57: 578–590

    Google Scholar 

  • Soyeur D (1986) Haemodynamic consequences of cardiac arrhythmias. In: Kulbertus HE (ed) Medical management of cardiac arrhythmias. Livingstone, Edinburgh, pp 26–40

    Google Scholar 

  • Velebit V, Podrid P, Lown B, Cohen BH, Graboys TB (1982) Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 65: 886–894

    Article  PubMed  CAS  Google Scholar 

  • Winkle RA, Mason JW, Griffin JC, Ross D (1981) Malignant ventricular arrhythmias associated with the use of encainide. Am Heart J 102: 857–864

    Article  Google Scholar 

  • Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta-blockade during and after myocardial infarction: an overview of the randomised trials. Prog Cardiovasc Dis 27: 335–371

    Article  Google Scholar 

Download references

Authors
  1. D. G. Julian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. C. Cowan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hertford College, Oxford University, 153 Woodstock Road, Oxford, OX2 7NA, Great Britain

    E. M. Vaughan Williams Professor Dr.

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Julian, D.G., Cowan, J.C. (1989). Successes and Limitations of Antiarrhythmic Drug Therapy. In: Vaughan Williams, E.M. (eds) Antiarrhythmic Drugs. Handbook of Experimental Pharmacology, vol 89. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73666-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73666-7_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73668-1

  • Online ISBN: 978-3-642-73666-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation